NCT03679221

Brief Summary

The overall objective of the proposal is to examine the association between depression and the newly reported "motoric cognitive risk" (MCR) syndrome, which is a pre-dementia syndrome combining subjective cognitive complaint (i.e.; memory complaint) with objective slow gait speed, in the Canadian population, with the baseline assessment of the Canadian Longitudinal Study on Aging (CLSA). The Canadian and global population are continuously aging. Moreover, the number of individuals affected by dementia is on the rise. One good predictor of dementia is Motoric Cognitive Risk (MCR) syndrome. MCR syndrome is a highly prevalent, newly defined syndrome that combines slow gait and subjective cognitive complaint. Depression is also highly prevalent in the older population and can affect both cognition and gait. Thus, an overlap between MCR and depression is possible. Yet few studies have examined the association between MCR and depression, thus emphasizing the importance of further investigating this association. This project encompasses determining the association of MCR syndrome with depression in the Canadian context as a step to better understand MCR syndrome in Canada.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 20, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

July 24, 2019

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

5.3 years

First QC Date

September 18, 2018

Last Update Submit

February 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjective cognitive complaint

    elicited from the 60-minute interview telephone questionnaire item Chronic Conditions Tracking (CTT\_19 CCT\_MEMPB\_TRM) done in CLSA study

    1 hour

Secondary Outcomes (1)

  • Slow gait speed

    1 day

Study Arms (4)

Group 45-54 years old

divided in two subgroups: individuals with and without cardio-vascular risk factors and diseases

Other: Data collection

Group 54-64 years old

divided in two subgroups: individuals with and without cardio-vascular risk factors and diseases

Other: Data collection

Group 65-74 years old

divided in two subgroups: individuals with and without cardio-vascular risk factors and diseases

Other: Data collection

Group 75-85 years old

divided in two subgroups: individuals with and without cardio-vascular risk factors and diseases

Other: Data collection

Interventions

telephone interview questionnaire, in-home face-to-face interview, and data from the Collection Site

Group 45-54 years oldGroup 54-64 years oldGroup 65-74 years oldGroup 75-85 years old

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals eligible for this study will be the participants of the CLSA

You may qualify if:

  • be participant of the comprehensive CLSA

You may not qualify if:

  • dementia,
  • mobility disability,
  • no information about cognitive complaint,
  • no measure of walking speed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Conditions

DepressionNeurocognitive Disorders

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Olivier Beauchet, MD

    Jewish General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Geriatrics

Study Record Dates

First Submitted

September 18, 2018

First Posted

September 20, 2018

Study Start

July 24, 2019

Primary Completion

October 31, 2024

Study Completion

December 1, 2025

Last Updated

February 23, 2024

Record last verified: 2024-02

Locations